This report expands the spectrum of ROS1 gene rearrangements in the IMT and highlights the importance of molecular analysis of IMT for getting a diagnostic clue and determining potential therapeutic strategies. This evidence concerns the gene ROS1 and inflammatory myofibroblastic tumor.